Liposomal Formulations of Cyclosporin A: Influence of Lipid Type and Dose on Pharmacokinetics
- 1 January 1995
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 12 (8) , 1189-1198
- https://doi.org/10.1023/a:1016220211925
Abstract
Purpose. Liposomal formulations of Cyclosporin A (CyA)3have been described in more than 30 publications to substitute Cremophor EL (CrEL), a triricinoleate ester of ethoxylated glycerol, as drug...Keywords
This publication has 25 references indexed in Scilit:
- Cyclosporin Clinical PharmacokineticsClinical Pharmacokinetics, 1993
- Erythrocyte Uptake and Protein Binding of Cyclosporin A(CyA) in Human Blood: Factors Affecting CyA Concentration in Erythrocytes.Biological & Pharmaceutical Bulletin, 1993
- Immunosuppressive effect of cyclosporine in the hyperlipidemic rat modelBiopharmaceutics & Drug Disposition, 1992
- Sterically stabilized liposomesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1992
- Cyclosporin leukoencephalopathy induced by intravenous lipid solutionThe Lancet, 1992
- Absorption kinetics of cyclosporin in the ratJournal of Pharmacy and Pharmacology, 1992
- Effect of co‐administration of intralipidTM on the pharmacokinetics of cyclosporine in the rabbitBiopharmaceutics & Drug Disposition, 1991
- Pharmacokinetics of two Alternative Dosage Forms for Cyclosporine: Liposomes and IntralipidJournal of Pharmaceutical Sciences, 1990
- Differentiation in hepatic and splenic phagocytic activity during reticuloendothelial blockade with cholesterol-free and cholesterol-rich liposomesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1986
- MEASUREMENTS OF RETICULOENDOTHEILLA SYSTEM PHAGOCYTIC ACTIVITY IN THE RAT AFTER TREATMENT WITH SILICA, LIPOSOMES, AND CYCLOSPORINETransplantation, 1985